Sign in
4

Changes in Ownership

Guardant Health, Inc. Filed Acc 0001753159-26-000012

Co-Chief Executive Officer sold 210,000 shares at an average $109.89 ($23,076,690)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Talasaz AmirAli · Co-Chief Executive Officer

Table I: Non-derivative

12 lines
Date Transaction Shares Price Value Owned after D/I
2026-05-20 Sale : show line 1 in the form 10b5-1 −200 $100.95 $20,190 2,096,304 I
2026-05-20 Sale : show line 2 in the form 10b5-1 −900 $102.57 $92,313 2,095,404 I
2026-05-20 Sale : show line 3 in the form 10b5-1 −1,366 $103.82 $141,815 2,094,038 I
2026-05-20 Sale : show line 4 in the form 10b5-1 −11,919 $105.01 $1,251,589 2,082,119 I
2026-05-20 Sale : show line 5 in the form 10b5-1 −1,200 $105.88 $127,050 2,080,919 I
2026-05-20 Sale : show line 6 in the form 10b5-1 −21,171 $106.99 $2,265,126 2,059,748 I
2026-05-20 Sale : show line 7 in the form 10b5-1 −33,069 $108.11 $3,574,961 2,026,679 I
2026-05-20 Sale : show line 8 in the form 10b5-1 −9,852 $108.97 $1,073,547 2,016,827 I
Open-market sales · 210,000 sh · avg $109.89 · $23,076,690
Loading xslF345X06/wk-form4_1779483475.xml…